Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the trea (Q44266818)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the trea	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the trea (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Starakis I

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Karravias D

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Asimakopoulos C

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kolaras P

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nikolaidis P

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Harlaftis N

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Skoutelis A

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Bassaris H

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

49-57

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Intraabdominal infection: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Bacteriology of Intra-abdominal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized Clinical Trial of Moxalactam Alone versus Tobramycin plus Clindamycin in Abdominal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. Joint Working Party of SIS North America and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistics notes: Absence of evidence is not evidence of absence

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of immunotherapy for asthma in allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(02)00248-0

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44266818&oldid=2109006762"